Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer’s Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia. Here, BGLAP is linked to early-onset autosomal dominant Alzheimer disease.